These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 16422182)

  • 21. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The coming of age of niche vaccines? Effect of vaccines on resistance profiles in Streptococcus pneumoniae.
    McGee L
    Curr Opin Microbiol; 2007 Oct; 10(5):473-8. PubMed ID: 17936680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era.
    Onwubiko C; Swiatlo E; McDaniel LS
    J Clin Microbiol; 2008 Nov; 46(11):3621-5. PubMed ID: 18845823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal vaccines: World Health Organization position paper.
    Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal conjugate vaccines. A review.
    Galiza EP; Heath PT
    Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevenar vaccination: review of the global data, 2006.
    Center KJ
    Vaccine; 2007 Apr; 25(16):3085-9. PubMed ID: 17287048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.
    Madhi SA; Adrian P; Kuwanda L; Jassat W; Jones S; Little T; Soininen A; Cutland C; Klugman KP
    Vaccine; 2007 Mar; 25(13):2451-7. PubMed ID: 17023095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical effectiveness of seven-valent pneumococcal conjugate vaccine (Prevenar) against invasive pneumococcal diseases: prospects for children in France].
    Black S; Shinefield H; Cohen R; Floret D; Gaudelus J; Olivier C; Reinert P
    Arch Pediatr; 2004 Jul; 11(7):843-53. PubMed ID: 15234383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic characteristics of pneumococcal disease in elderly patients before introducing the pneumococcal conjugate vaccine.
    Pichon B; Bennett HV; Efstratiou A; Slack MP; George RC
    Epidemiol Infect; 2009 Jul; 137(7):1049-56. PubMed ID: 19161642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [7-valent conjugate Pneumococcal vaccine and nasopharyngeal cavity].
    Piffer S
    Ann Ig; 2002; 14(6 Suppl 7):31-7. PubMed ID: 12638362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Present view of conjugated pneumococcus vaccines].
    Prymula R
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):98-102. PubMed ID: 17051470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
    Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
    Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pneumococcal vaccine: protection of adults and reduction of antibiotic resistence by vaccination of children with a conjugated vaccine].
    Pletz MW
    Med Monatsschr Pharm; 2011 Jun; 34(6):201-5. PubMed ID: 21812250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.